Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy L Olson

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Journal of Thoracic Imaging|August 2, 2018
Pulmonary Manifestations of Common Variable ImmunodeficiencyTami J Bang, John Caleb Richards, Amy L Olson, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2007
Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003Amy L Olson, Jeffrey J Swigris, Dennis C Lezotte, et al.
Advances in Therapy|February 24, 2022
Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database AnalysisAmy L Olson, Nadine Hartmann, Padmaja Patnaik, et al.
Multidisciplinary Respiratory Medicine|December 23, 2015
Supplemental oxygen users with pulmonary fibrosis perceive greater dyspnea than oxygen non-usersMengshu Cao, Frederick S Wamboldt, Kevin K Brown, et al.
The Journal of Rheumatology|November 17, 2018
Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and MortalityKarina Raimundo, Joshua J Solomon, Amy L Olson, et al.
BMC Pulmonary Medicine|November 14, 2025
Real-world clinical and economic outcomes associated with supplemental oxygen therapy use among patients with fibrosing interstitial lung disease in the United StatesJoseph Yang, Andrea Steffens, Lee Brekke, et al.
American Journal of Respiratory and Critical Care Medicine|February 19, 2011
Sarcoidosis-related mortality in the United States from 1988 to 2007Jeffrey J Swigris, Amy L Olson, Tristan J Huie, et al.
Respiratory Medicine|February 3, 2012
Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at deathJeffrey J Swigris, Amy L Olson, Tristan J Huie, et al.
Chest|May 14, 2011
Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007Jeffrey J Swigris, Amy L Olson, Tristan J Huie, et al.
Advances in Therapy|May 27, 2020
Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USAAmy L Olson, Toby M Maher, Valentina Acciai, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Journal of Thoracic Imaging|August 2, 2018
Pulmonary Manifestations of Common Variable ImmunodeficiencyTami J Bang, John Caleb Richards, Amy L Olson, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2007
Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003Amy L Olson, Jeffrey J Swigris, Dennis C Lezotte, et al.
Advances in Therapy|February 24, 2022
Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database AnalysisAmy L Olson, Nadine Hartmann, Padmaja Patnaik, et al.
Multidisciplinary Respiratory Medicine|December 23, 2015
Supplemental oxygen users with pulmonary fibrosis perceive greater dyspnea than oxygen non-usersMengshu Cao, Frederick S Wamboldt, Kevin K Brown, et al.
The Journal of Rheumatology|November 17, 2018
Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and MortalityKarina Raimundo, Joshua J Solomon, Amy L Olson, et al.
BMC Pulmonary Medicine|November 14, 2025
Real-world clinical and economic outcomes associated with supplemental oxygen therapy use among patients with fibrosing interstitial lung disease in the United StatesJoseph Yang, Andrea Steffens, Lee Brekke, et al.
American Journal of Respiratory and Critical Care Medicine|February 19, 2011
Sarcoidosis-related mortality in the United States from 1988 to 2007Jeffrey J Swigris, Amy L Olson, Tristan J Huie, et al.
Respiratory Medicine|February 3, 2012
Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at deathJeffrey J Swigris, Amy L Olson, Tristan J Huie, et al.
Chest|May 14, 2011
Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007Jeffrey J Swigris, Amy L Olson, Tristan J Huie, et al.
Advances in Therapy|May 27, 2020
Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USAAmy L Olson, Toby M Maher, Valentina Acciai, et al.
Pageof 6